CompletedNot applicableNCT00136344

Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery

Studying Endophthalmitis

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: City, University of London
Principal Investigator: Peter Barry, FRCS
ESCRS (European Society of Cataract and Refractive Surgeons)
Intervention: Cefuroxime(drug)
Enrollment: 35000 enrolled
Eligibility: 18 years · All sexes
Timeline: 2003 – 2006

Study locations (24)

University Eye Clinic, Paracelsus Private Medical University, Salzburg, Austria
University Hospital Antwerp, UZA Ophthalmology, Antwerp, Belgium
University of Gent, Universitaire Zeikenhuis, Ghent, Belgium
Jan Yperman Ziekenhuis, Ieper, Belgium
Centre Hospitalier Universitaire, Liège, Belgium
Oogheelkunde, Melveren, Belgium
Augenklinik Ahaus, Ahaus, Germany
Azienda Ospedaliera di Desenzano del Garda, Desenzano, Italy
Ospedale Borgo Trento, Verona, Italy
Kierownik Katedry i Kliniki, Warsaw, Poland
University Hospital, Coimbra, Portugal
Instituto Oftalmologico VISSUM, Alicante, Spain
La Candelaria University Hospital, La Candelaria, Tenerife, Spain
Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Hospital Oftalmologico Internacional, Madrid, Spain
+9 more locations on ClinicalTrials.gov

Collaborators

The European Society of Cataract and Refractive Surgeons(ESCRS) · Santen Gmbh

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00136344 on ClinicalTrials.gov

Other trials for Endophthalmitis

Additional recruiting or active studies for the same condition.

See all trials for Endophthalmitis →

← Back to all trials